Literature DB >> 10466686

Pemphigus and bullous pemphigoid.

H C Nousari1, G J Anhalt.   

Abstract

Pemphigus and bullous pemphigoid are distinct autoimmune blistering diseases that are characterised by the presence of autoantibodies directed against specific adhesion molecules of the skin and mucous membranes. The comparison and contrast of molecular mechanism of blister formation of these two diseases provide a rational diagnostic and therapeutic approach to affected patients.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10466686     DOI： 10.1016/S0140-6736(99)03007-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  28 in total

1.  Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity.

Authors:  V T Nguyen; A Ndoye; S A Grando
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Widespread dermal ulcerations and bullae.

Authors:  Jay Wofford; Mahir Patel; Allison Readinger; Alan Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-04

3.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 4.  Intravenous immunoglobulin for treatment of pemphigus.

Authors:  Lehavit Akerman; Daniel Mimouni; Michael David
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 5.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  The role of topical corticosteroids in bullous pemphigoid in the elderly.

Authors:  Pascal Joly; Juliette Fontaine; Jean-Claude Roujeau
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 7.  Complement and cutaneous autoimmune blistering diseases.

Authors:  Elizabeth Lessey; Ning Li; Luis Diaz; Zhi Liu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  A patient with multiple blisters in the skin and mucous membranes.

Authors:  Antonio G Tristano
Journal:  BMJ Case Rep       Date:  2010-01-13

9.  The value of ultrahigh resolution OCT in dermatology - delineating the dermo-epidermal junction, capillaries in the dermal papillae and vellus hairs.

Authors:  Niels Møller Israelsen; Michael Maria; Mette Mogensen; Sophie Bojesen; Mikkel Jensen; Merete Haedersdal; Adrian Podoleanu; Ole Bang
Journal:  Biomed Opt Express       Date:  2018-04-19       Impact factor: 3.732

10.  Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases.

Authors:  Ning Li; Minglang Zhao; Julio Hilario-Vargas; Phillip Prisayanh; Simon Warren; Luis A Diaz; Derry C Roopenian; Zhi Liu
Journal:  J Clin Invest       Date:  2005-11-10       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.